Modelling HIV epidemics in the antiretroviral era: the UNAIDS Estimation and Projection package 2009

Objective The UNAIDS Estimation and Projection Package (EPP) is a tool for country-level estimation and short-term projection of HIV/AIDS epidemics based on fitting observed HIV surveillance data on prevalence. This paper describes the adaptations made in EPP 2009, the latest version of this tool, as new issues have arisen in the global response, in particular the global expansion of antiretroviral therapy (ART). Results By December 2008 over 4 million people globally were receiving ART, substantially improving their survival. EPP 2009 required modifications to correctly adjust for the effects of ART on incidence and the resulting increases in HIV prevalence in populations with high ART coverage. Because changing incidence is a better indicator of program impact, the 2009 series of UNAIDS tools also focuses on calculating incidence alongside prevalence. Other changes made in EPP 2009 include: an improved procedure, incremental mixture importance sampling, for efficiently generating more accurate uncertainty estimates; provisions to vary the urban/rural population ratios in generalised epidemics over time; introduction of a modified epidemic model that accommodates behaviour change in low incidence settings; and improved procedures for calibrating models. This paper describes these changes in detail, and discusses anticipated future changes in the next version of EPP.

[1]  J. Williamson POPULATION AND DEVELOPMENT REVIEW , 2011 .

[2]  U. Unicef,et al.  Global HIV/AIDS response: epidemic update and health sector progress towards universal access: progress report 2011. , 2011 .

[3]  Adrian E Raftery,et al.  Estimating and Projecting Trends in HIV/AIDS Generalized Epidemics Using Incremental Mixture Importance Sampling , 2010, Biometrics.

[4]  A. Zaslavsky,et al.  Flexible epidemiological model for estimates and short-term projections in generalised HIV/AIDS epidemics , 2010, Sexually Transmitted Infections.

[5]  A. Raftery,et al.  A stochastic infection rate model for estimating and projecting national HIV prevalence rates , 2010, Sexually Transmitted Infections.

[6]  Connie Celum,et al.  Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis , 2010, The Lancet.

[7]  G. Rutherford,et al.  Optimal time for initiation of antiretroviral therapy in asymptomatic, HIV-infected, treatment-naive adults. , 2010, The Cochrane database of systematic reviews.

[8]  Matthias Egger,et al.  Sexual transmission of HIV according to viral load and antiretroviral therapy: systematic review and meta-analysis , 2009, AIDS.

[9]  Stephen R Cole,et al.  Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies , 2009, The Lancet.

[10]  R. Hogg,et al.  HIV/AIDS in Vancouver, British Columbia: a growing epidemic , 2009, Harm reduction journal.

[11]  Organización Mundial de la Salud,et al.  Towards universal access: scaling up priority HIV/AIDS interventions in the health sector. Progress report 2009 , 2009 .

[12]  T. Moeti,et al.  Estimated HIV Trends and Program Effects in Botswana , 2008, PloS one.

[13]  M. Zwahlen,et al.  Duration from seroconversion to eligibility for antiretroviral therapy and from ART eligibility to death in adult HIV-infected patients from low and middle-income countries: collaborative analysis of prospective studies , 2008, Sexually Transmitted Infections.

[14]  E. Gouws,et al.  Comparison of adult HIV prevalence from national population-based surveys and antenatal clinic surveillance in countries with generalised epidemics: implications for calibrating surveillance data , 2008, Sexually Transmitted Infections.

[15]  A. Raftery,et al.  Bayesian melding for estimating uncertainty in national HIV prevalence estimates , 2008, Sexually Transmitted Infections.

[16]  T Brown,et al.  Progress and challenges in modelling country-level HIV/AIDS epidemics: the UNAIDS Estimation and Projection Package 2007 , 2008, Sexually Transmitted Infections.

[17]  Jim Todd,et al.  Time from HIV seroconversion to death: a collaborative analysis of eight studies in six low and middle-income countries before highly active antiretroviral therapy , 2007, AIDS.

[18]  Adrian E. Raftery,et al.  Probabilistic projections of HIV prevalence using Bayesian melding. , 2007, 0709.0421.

[19]  Adrian E. Raftery,et al.  Computing Normalizing Constants for Finite Mixture Models via Incremental Mixture Importance Sampling (IMIS) , 2006 .

[20]  N. Grassly,et al.  Improving projections at the country level: the UNAIDS Estimation and Projection Package 2005 , 2006, Sexually Transmitted Infections.

[21]  J. Garcia-Calleja,et al.  National population based HIV prevalence surveys in sub-Saharan Africa: results and implications for HIV and AIDS estimates , 2006, Sexually Transmitted Infections.

[22]  X. Sun,et al.  Estimating the number of people at risk for and living with HIV in China in 2005: methods and results , 2006, Sexually Transmitted Infections.

[23]  M. Matee,et al.  Estimating and projecting HIV prevalence and AIDS deaths in Tanzania using antenatal surveillance data , 2006, BMC public health.

[24]  J Stover,et al.  The UNAIDS Estimation and Projection Package: a software package to estimate and project national HIV epidemics , 2004, Sexually Transmitted Infections.

[25]  T. Dyson HIV / AIDS and urbanization. , 2003 .

[26]  Treat Million by Initiative Treating 3 million by 2005. Making it happen: the WHO strategy. The WHO and UNAIDS global initiative to provide antiretroviral therapy to 3 million people with HIV/AIDS in developing countries by the end of 2005 , 2003 .

[27]  Modelling Improved methods and assumptions for estimation of the HIV/AIDS epidemic and its impact: Recommendations of the UNAIDS Reference Group on Estimates, Modelling and Projections. , 2002, AIDS.